Skip to main content
. Author manuscript; available in PMC: 2016 Jun 24.
Published in final edited form as: Curr Treat Options Neurol. 2014 Nov;16(11):319. doi: 10.1007/s11940-014-0319-0
Standard dosage oral 200 mg to 800 mg twice to three times daily
Contraindications concomitant MAOi use, concomitant use of nonnucleoside reverse transcrip-
tase inhibitors, hypersensitivity to tricyclic antidepressants (TCA), bone marrow
depression; avoid abrupt withdrawal
Main drug interactions medications associated with CYP1A2, 2B6, 2C, 3A4 pathways as carbamaze-
pine is an inducer.
Main side effects rash, myelosuppresion, hepatitis, hyponatremia, syndrome of inappropriate
antidiuretic hormone secretion (SIADH), pancreatitis, congenital
malformations, seizures, dizziness, drowsiness, blurred vision, impaired
coordination
Special points carbamazepine is a significant inducer of its own metabolism and serum levels
may decrease after chronic use
Cost inexpensive
Standard dosage 25 mg to 200 mg daily or twice daily
Contraindications avoid abrupt withdrawal
Main drug interactions carbonic anhydrase inhibitors, oral contraceptives
Main side effects metabolic acidosis, nephrolithiasis, osteoporosis, hypokalemia, rash, glauco-
ma, paresthesias, weight loss, somnolence, cognitive dysfunction
Special points topiramate has significant cognitive dysfunction side effects, regular ophthal-
mological exam for glaucoma recommended
Cost expensive compared to other oral agents